Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Peter, Laverman"'
CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis
Autor:
Wessel F. Theeuwes, Irene Di Ceglie, Daphne N. Dorst, Arjen B. Blom, Desiree L. Bos, Thomas Vogl, Sander W. Tas, Pilar Jimenez-Royo, Mats Bergstrom, Matthew Cleveland, Peter M. van der Kraan, Peter Laverman, Marije I. Koenders, Peter L. van Lent, Martijn H. J. van den Bosch
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background Rheumatoid arthritis (RA) is one of the most prevalent and debilitating joint diseases worldwide. RA is characterized by synovial inflammation (synovitis), which is linked to the development of joint destruction. Magnetic resonanc
Externí odkaz:
https://doaj.org/article/2aad6123f8ac4ee5adcf05a7f4fb72f2
Autor:
Oliver C. Kiss, Peter J. H. Scott, Martin Behe, Ivan Penuelas, Jan Passchier, Ana Rey, Marianne Patt, Silvio Aime, Amir Jalilian, Peter Laverman, Zhen Cheng, Alain Faivre Chauvet, Jonathan Engle, Frederik Cleeren, Hua Zhu, Johnny Vercouillie, Michael van Dam, Ming Rong Zhang, Lars Perk, Benjamin Guillet, Francisco Alves
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-18 (2023)
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body This selection of highlights provides
Externí odkaz:
https://doaj.org/article/10468f03ff4e4a0fb2f2efed6a746361
Autor:
Emerson Bernardes, Peter Caravan, R. Michael van Dam, Winnie Deuther-Conrad, Beverley Ellis, Shozo Furumoto, Benjamin Guillet, Ya-Yao Huang, Hongmei Jia, Peter Laverman, Zijing Li, Zhaofei Liu, Filippo Lodi, Yubin Miao, Lars Perk, Ralf Schirrmacher, Johnny Vercoullie, Hua Yang, Min Yang, Xing Yang, Junbo Zhang, Ming-Rong Zhang, Hua Zhu
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 7, Iss 1, Pp 1-17 (2022)
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resul
Externí odkaz:
https://doaj.org/article/c5700f1006a6427595afeca427a323cc
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-21 (2021)
Abstract Background The translocator protein 18 kDa is recognised as an important biomarker for neuroinflammation due to its soaring expression in microglia. This process is common for various neurological disorders. DPA-714 is a potent TSPO-specific
Externí odkaz:
https://doaj.org/article/d61a2760993b45019c9ee1e8a85c2059
Autor:
Roel C. Op ‘t Veld, Lieke Joosten, Peter Laverman, Ewald M. Bronkhorst, John A. Jansen, X. Frank Walboomers, Frank A. D. T. G. Wagener
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5127 (2023)
Polyisocyanopeptide (PIC) hydrogels are proposed as promising wound dressings. These gels are thermo-sensitive, allow application as a cold liquid, and rely on gelation through body heat. It is supposed that the gel can be easily removed by reversing
Externí odkaz:
https://doaj.org/article/87af2ed1eff5428b929af89254931ee7
Autor:
Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Oliver Neels, Meltem Ocak, Marianne Patt, Sergio Todde
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-22 (2021)
Abstract This guideline on current good radiopharmacy practice (cGRPP) for small-scale preparation of radiopharmaceuticals represents the view of the Radiopharmacy Committee of the European Association of Nuclear Medicine (EANM). The guideline is lai
Externí odkaz:
https://doaj.org/article/bc7de423197d4be2b0ea1a371b29aa4d
Autor:
Nic Gillings, Sergio Todde, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Olaug Hjelstuen, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Meltem Ocak, Marianne Patt
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-29 (2020)
Abstract Background To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The International Conference on Harmonization of Technical Requirements for Registrati
Externí odkaz:
https://doaj.org/article/cc45c06314a7408c8bffce0df6f67c8c
Autor:
Anton Amadeus Hörmann, Maximilian Klingler, Christine Rangger, Christian Mair, Lieke Joosten, Gerben M. Franssen, Peter Laverman, Elisabeth von Guggenberg
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 796 (2023)
The therapeutic potential of minigastrin (MG) analogs for the treatment of cholecystokinin-2 receptor (CCK2R)-expressing cancers is limited by poor in vivo stability or unfavorable accumulation in non-target tissues. Increased stability against metab
Externí odkaz:
https://doaj.org/article/cce9ff54695d4e17bf4864ac9c1fe04e
Autor:
Daphne N. Dorst, Marti Boss, Mark Rijpkema, Birgitte Walgreen, Monique M. A. Helsen, Desirée L. Bos, Louis van Bloois, Gerrit Storm, Maarten Brom, Peter Laverman, Peter M. van der Kraan, Mijke Buitinga, Marije I. Koenders, Martin Gotthardt
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1868 (2021)
Macrophages play a crucial role in the initiation and progression of rheumatoid arthritis (RA). Liposomes can be used to deliver therapeutics to macrophages by exploiting their phagocytic ability. However, since macrophages serve as the immune system
Externí odkaz:
https://doaj.org/article/e70353bcaa8c4f038122e08e45552458
Autor:
Monique M. Helsen, Andreas Ramming, Mark Rijpkema, Marije I. Koenders, Evan Brennan, Daphne N. Dorst, Georg Schett, Birgitte Walgreen, Peter M. van der Kraan, Martin Gotthardt, Torsten Kuwert, Peter Laverman, Christian Klein, Mijke Buitinga, Christian Schmidkonz
Publikováno v:
Rheumatology, 61, 7, pp. 2999-3009
Rheumatology, 61(7), 2999-3009. Oxford University Press
Rheumatology, 61, 2999-3009
Rheumatology, 61(7), 2999-3009. Oxford University Press
Rheumatology, 61, 2999-3009
Objective Activated synovial fibroblasts are key effector cells in RA. Selectively depleting these based upon their expression of fibroblast activation protein (FAP) is an attractive therapeutic approach. Here we introduce FAP imaging of inflamed joi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80373699558d9540d4b6624b47866e55
https://hdl.handle.net/2066/282880
https://hdl.handle.net/2066/282880